Eligible organizations are invited to submit their applications by downloading the attached document and emailing it to, grants.donations@immunocore.com. Applications will be reviewed collectively by the Immunocore Grants and Donations Committee. Please allow four weeks for a decision.

Written agreements associated with Grants & Donations must include:

• Description of the grant.
• Objective of the grant (including details on how it will support healthcare, scientific research or education).
• The names of the organizations / parties involved, and their respective roles.
• The type of activity and the nature of the company’s contribution.
• The timeframe.
• The amount of funding and/or a description of indirect/non-financial, in-kind donation and the nature of that donation. Where possible a full breakdown of costs should be included.
• A statement that all parties are fully aware that the grant must be clearly acknowledged and apparent from the outset.
• The signatories to the agreement
• The date of the agreement

Requests for grants and donations from healthcare organizations (HCOs), patient organizations, and academic/research institutions must be assessed to ensure compliance with the ABPI Code of Practice when requests are received from UK healthcare organizations, patient organizations and other organizations, the EFPIA Code and the applicable national legislation when requests are received from European entities, and the PhRMA Code, federal anti-kickback laws, and FDA regulations and guidance, when requests are received from US-based entities.

Requirements that need to be met for Immunocore to consider support of your application include, but are not limited to the following:

• Grants and donations to healthcare organizations, patient organizations or other organizations are only allowed if they:
  • You are qualified in terms of background, education, and experience to conduct and complete the proposed research
  • You are not debarred, disqualified, restricted or excluded from engaging in activities relating to development or approval of drugs by any regulatory authority
  • If research involves treatment of patients, your license is current
  • You assume all responsibilities and obligations to comply with all relevant laws and regulatory requirements (e.g., Good Clinical Practice and safety reporting regulations)
  • You or your appointed representative holds the IND or equivalent clinical trial authorization (as applicable)
  • You provide safety reports to Immunocore, in accordance with the research agreement
  • You provide study status updates in accordance with the research agreement
  • You submit the final study report and manuscript, as applicable and in accordance with the research agreement

User Guide for Submissions

• Immunocore portal user guide